Eterna (ERNA) Therapeutics announced a successful inaugural meeting of its newly formed Scientific Advisory Board, SAB. The meeting brought together leading experts in cell therapy to evaluate preclinical advances, address key scientific questions, refine the company’s research and development priorities, and discuss the roadmap to human clinical trials. The board consists of leaders in the field, including: Michael Andreeff; Christopher Rohde; Blythe Sather; Jerome B. Zeldis
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERNA: